Incidence of SARS-CoV-2 (COVID-19) -associated pulmonary aspergillosis (CAPA) before and after dexamethasone therapy - a retrospective analysis : Incidence of SARS-CoV-2 (COVID-19) -associated pulmonary aspergillosis (CAPA) before and after dexamethasone therapy - a retrospective analysis - COVID DEXA

Media Type:

Clinical Trial

Year of Publication:

2021

Publication:

2021

Contained In:

WHO International Clinical Trials Registry Platform - (2021) vom: 01. Nov. To Main Record - year:2021

Language:

Unbestimmt

Links:

Volltext [kostenfrei]

Keywords:

610
Medical Condition: ;B44.0 - Invasive pulmonary aspergillosis
Recruitment Status: Recruiting
Study Type: Observational

Notes:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 23-08-2021, Last updated: 2021-11-08

PPN (Catalogue-ID):

WHO007843062